OPKO Health (LTS:0KCS) Short-Term Debt: $9.6 Mil (As of Mar. 2026)


LTS:0KCS OPKO Health Inc LTS:0KCS
57 GF Score
Price $1.35
GF Value $1.06
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is OPKO Health Short-Term Debt?

OPKO Health LTS:0KCS -2.88% 57 Short-Term Debt is $9.6 Mil as of Mar. 2026. GuruFocus rates LTS:0KCS with a GF Score™ of 57/100 and a GF Value™ of $1.06 (Modestly Overvalued). The stock has 4 warning signs investors should review.

OPKO Health's Short-Term Debt for the quarter that ended in Mar. 2026 was $9.6 Mil.

OPKO Health's quarterly Short-Term Debt declined from Sep. 2025 ($12.8 Mil) to Dec. 2025 ($10.3 Mil) and declined from Dec. 2025 ($10.3 Mil) to Mar. 2026 ($9.6 Mil).

OPKO Health's annual Short-Term Debt declined from Dec. 2023 ($27.3 Mil) to Dec. 2024 ($15.0 Mil) and declined from Dec. 2024 ($15.0 Mil) to Dec. 2025 ($10.3 Mil).

OPKO Health Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

OPKO Health Short-Term Debt Related Terms

OPKO Health Short-Term Debt Historical Data

* Premium members only.

The historical data trend for OPKO Health's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health Short-Term Debt Chart

OPKO Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.69 36.59 27.29 15.02 10.25

OPKO Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 113.39 14.02 12.79 10.25 9.65
LTS:0KCS
57GF Score
OPKO Health Inc LTS:0KCS
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $9.6 Mil mean?
OPKO Health (LTS:0KCS) has a Short-Term Debt of $9.6 Mil as of Mar. 2026.
Is OPKO Health's Short-Term Debt too high?
OPKO Health's current Short-Term Debt is $9.6 Mil. Overall, OPKO Health has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's Short-Term Debt compare to PSNL and CDNA?
OPKO Health's Short-Term Debt of $9.6 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Diagnostics & Research company?
A good Short-Term Debt depends on the Medical Diagnostics & Research industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. OPKO Health's current Short-Term Debt is $9.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (LTS:0KCS) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.06, compared to a current price of $1.35 — trading 27.4% above its estimated fair value. The current Short-Term Debt is $9.6 Mil. OPKO Health's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For OPKO Health (LTS:0KCS), the current Short-Term Debt is $9.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OPKO Health (LTS:0KCS) Overvalued in 2026?

Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued. The current stock price of $1.35 is trading 27.4% above its estimated GF Value™ of $1.06. GuruFocus considers OPKO Health to be Modestly Overvalued.

Key valuation signals for LTS:0KCS:

  • Short-Term Debt: $9.6 Mil
  • GF Value™: $1.06 vs. price of $1.35 (27.4% above fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the LTS:0KCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OPKO Health Business Description

Address 4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
57GF Score

Get the complete analysis for LTS:0KCS

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.35
Price
$1.06
GF Value